文献速递糖尿病

尿液生化检测揭示2型糖尿病年度复查者心血管药物依从性低

Biochemical Urine Testing of Adherence to Cardiovascular Medications Reveals High Rates of Nonadherence in People Attending Their Annual Review for Type 2 Diabetes.
PubMed 文献 · Diabetes Care · 2019-03-18

该研究采用液相色谱-串联质谱法(LC-MS/MS)检测228例基层2型糖尿病患者的常规尿液样本,评估心血管药物依从性。结果显示28.1%患者对降糖、降压和/或降脂药物不依从,他汀类不依从率最高达23.7%,口服降糖药为9.3%。不依从者HbA1c、白蛋白与肌酐比值及血脂水平显著高于依从者。

要点

  • 常规尿液LC-MS/MS可客观筛查2型糖尿病患者的药物不依从性。
  • 他汀类不依从率最高(23.7%),口服降糖药为9.3%。
  • 不依从者血糖、蛋白尿及血脂控制更差。

核心结论

  • 常规尿液样本可用于LC-MS/MS依从性筛查,2型糖尿病患者不依从率较高,尤其他汀类。

研究设计与样本

  • 研究纳入基层228例2型糖尿病患者的年度复查常规尿液样本,采用LC-MS/MS检测药物依从性。

主要发现

  • 28.1%患者(N=64)对降糖、降压和/或降脂药物不依从。
  • 他汀类不依从率最高为23.7%,口服降糖药不依从率为9.3%。
  • 不依从者HbA1c、白蛋白与肌酐比值及血脂谱显著高于依从者。

临床怎么用

  • 可考虑将常规尿液LC-MS/MS作为客观评估心血管药物依从性的筛查工具。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is a new method to objectively and robustly detect nonadherence. We applied this technique to study nonadherence to cardiovascular medications in people with type 2 diabetes (T2DM). RESEARCH DESIGN AND METHODS: Routine urine samples, received at the time of the annual diabetes review from 228 people with T2DM in primary care, were assessed for adherence by LC-MS/MS. RESULTS: A total of 28.1% patients (N = 64) were nonadherent to antidiabetic, antihypertensive, and/or lipid-lowering medications. Nonadherence to statins was the highest at 23.7%, and nonadherence to oral hypoglycemic agents was 9.3%. HbA1c, albumin-to-creatinine ratio, and lipid profiles were significantly higher in the patients who were nonadherent compared with those who were adherent to treatment. CONCLUSIONS: This unique study shows that routine urine samples can be used for adherence testing screening by LC-MS/MS and has demonstrated high nonadherence rates especially to statins in people with T2DM. Future intervention studies using LC-MS/MS as a diagnostic/therapeutic tool may help to improve clinical outcomes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Patel P, Gupta P, Burns A, et al. Biochemical Urine Testing of Adherence to Cardiovascular Medications Reveals High Rates of Nonadherence in People Attending Their Annual Review for Type 2 Diabetes. Diabetes Care. 2019. PMID: 30885952. doi:10.2337/dc18-1453

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。